OGA @OGA_Community Community with a primary goal of increasing the availability and use of high-performance antibodies.
Joined June 2023
- Tweets144
- Following113
- Followers74
- Likes150
OnlyGoodAntibodies retweeted
✍️🚨Check out this *new #blog* from the #NIHRLeicesterBRC's @Harvin_Der_Virk “New protocol will drive a shared roadmap towards more reliable and cost-effective use of #antibodies in biomedical research.” including links to papers published in @natureprotocols this month. @OGA_Community leicesterbrc.nihr.ac.uk/harv…
ALT Dr Harvinder Virk
OnlyGoodAntibodies retweeted
FUNDED 💰 PHD 🎓 OPPORTUNITY 🙋♀️ . Starts Sept 2025, apply via University of Leicester, funded via BBSRC MIBTP.
If you are interested, please contact me!
This project will work towards the discovery and validation of immune ageing biomarkers.
le.ac.uk/study/research-degr…
OnlyGoodAntibodies retweeted
It’s very encouraging that funders support projects like YCharOS, which does not address hypotheses, but rather does the foundational, but not sexy, work of testing and characterizing reagent antibodies in order to make everyone else’s science more robust and reproducible.
CQDM is proud to announce the funding of a collaborative research project made possible through a grant of nearly Can$1.49M from the Government of Quebec (@economie_quebec). A project of @YCharOS1 in partnership with @mcgillu.
👉cqdm.org/en/news-and-events/…
OnlyGoodAntibodies retweeted
Non-animal derived antibodies and affinity reagents are part of the solution. We are working to accelerate their uptake as alternatives to traditional antibodies that are more reproducible and replace animal use.
nc3rs.org.uk/news/recommenda….
OnlyGoodAntibodies retweeted
We are working with the OGA to raise awareness of the importance of improving reproducibility of research involving antibodies, for better science that is more efficient, reliable and reduces or replaces the use of animals.
nc3rs.org.uk/news/improving-…
OnlyGoodAntibodies retweeted
Fantastic to see our work with the @OGA_Community
highlighted in this article. Poor antibodies waste research funding and time, delay scientific progress and drug development, and lead to unnecessary animal use where in vivo experiments or animal-derived products are involved.
Poorly performing antibodies have plagued biomedical sciences for decades. Several fresh initiatives hope to change this go.nature.com/3NYdY42
OnlyGoodAntibodies retweeted
Fantastic to see this Nature feature article promoting our work with @OGA_Community and @YCharOS1.
We aim to promote a change in biomedical research culture and #openscience practices with a specific focus on antibody validation.
Thank you to @Nature and Diana Kwon for featuring @YCharOS1 and our community - and showing the progress we are making!
nature.com/articles/d41586-0…
OnlyGoodAntibodies retweeted
Poorly performing antibodies have plagued biomedical sciences for decades. Several fresh initiatives hope to change this go.nature.com/3NYdY42
OnlyGoodAntibodies retweeted
Thank you @DianaMKwon for the great news feature in Nature about the public good YCharOS effort
Thrilled to see our own @CarlLaflamme4 and Riham Ayoubi featured in this Nature article for their fantastic antibody characterization work!
OnlyGoodAntibodies retweeted
Neuroscientist Carl Laflamme describes @YCharOS1, an initiative testing commercial antibodies to determine if they work as advertised, and making findings open to improve research efficiency and reproducibility. via @Nature
buff.ly/40AgsNn
#OpenScience
Thank you to @Nature and Diana Kwon for featuring @YCharOS1 and our community - and showing the progress we are making!
nature.com/articles/d41586-0…
OnlyGoodAntibodies retweeted
@Harvin_Der_Virk #EMIRA speaking to the challenges of progressing drug development & research alongside MDT assessment delays... strategies afoot including YCHARUS better antibodies better science better patient outcomes @amandatatler @bedoctored @ild_inn
Better antibodies, better science, better treatments.
le.ac.uk/research/institutes…
OnlyGoodAntibodies retweeted
🎉Celebrating a new milestone: Over 100 antibody characterization reports #openly available on our Zenodo community, with several converted to peer-reviewed F1000 publications!
➡️zenodo.org/communities/ychar…
➡️f1000research.com/gateways/y…
OnlyGoodAntibodies retweeted
Excited to share our @eLife review about the ongoing “antibody characterization crisis”
and potential solutions. Nice effort by @Harvin_Der_Virk, @CarlLaflamme4, Jim
Trimmer, Meghan Rego, IPI’s Rob Meijers and others. Read the paper here:
bit.ly/472uUiB
Thank you to Rick Kahn, @eLife and all of the co-authors for this excellent overview of initiatives that have and are improving science using antibodies.
Keep up the good work everyone!
doi.org/10.7554/eLife.100211
The @NC3Rs and OGA community: bringing together stakeholders from across the biosciences to improve the integrity and reproducibility of biomedical research that relies on commercial antibodies.
nc3rs.org.uk/news/improving-…